PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Same cell death pathway involved in three forms of blindness, Penn team finds

2014-01-17
(Press-News.org) Contact information: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania
Same cell death pathway involved in three forms of blindness, Penn team finds

Gene therapies developed by University of Pennsylvania School of Veterinary Medicine researchers have worked to correct different forms of blindness. While effective, the downside to these approaches to vision rescue is that each disease requires its own form of gene therapy to correct the particular genetic mutation involved, a time consuming and complex process.

Hoping to develop a treatment that works more broadly across diseases, a Penn Vet team used canine disease models to closely examine how retinal gene activity varied during the progression of three different forms of inherited vision disease. Their results turned up an unexpected commonality: Early on in each of the diseases, genes involved in the same specific pathway of cell death appeared to be activated. These findings point to possible interventions that could curb vision loss across a variety of inherited retinal diseases.

The work, published in PLOS ONE, was conducted by Sem Genini, a senior research investigator; William A. Beltran, assistant professor of ophthalmology; and Gustavo D. Aguirre, professor of medical genetics and ophthalmology, all of Penn Vet's Department of Clinical Studies, Philadelphia.

The team examined three forms of retinal degenerative diseases, rod cone dysplasia 1 being the most severe, or earliest onset, followed by X-linked progressive retinal atrophy 2 and then early retinal degeneration. All of these diseases involve the death of photoreceptor cells and each is caused by a distinct genetic mutation. But what scientists did not know is how the mutations trigger a molecular signaling pathway that leads to the death of photoreceptor cells.

"What we have in mind is to be able to address multiple forms of disease with one treatment," Beltran said. "We wanted to get a better understanding of whether there are any common cell death or cell survival pathways that could be targeted in some of these diseases."

The researchers looked at the activity of 112 genes in diseased retinas and compared it to gene activity in normal retinas. They assessed gene activity at time points known to correspond with key phases of disease: the "induction phase," the time before the peak level of photoreceptor cell death; the "execution phase," when the highest rates of photoreceptor cell death occur; and the "chronic phase," during which photoreceptor cell death continues at somewhat reduced levels.

During the execution and chronic phases of disease, the researchers identified a number of genes involved in programmed cell death, or apoptosis, that had noticeably different patterns of expression between the diseased and normal dogs.

Of note, several proteins involved in the tumor necrosis factor, or TNF, pathway increased in activity during the induction and execution phases. This pathway is implicated in many diseases, from diabetes to cancer to rheumatoid arthritis.

"This is quite a new result," Genini said. "It was not expected to have the TNF pathway upregulated."

"We assumed," Aguirre said, "the diseases would be different from one another and that cells would commit suicide by their own specific pathway and that perhaps quite late they would have a common final pathway. But what this shows is that there is an early trigger that is quite similar among all three diseases."

An additional surprise was that the differentially expressed proteins were present not only in photoreceptor cells but also in other cells in the retina, including horizontal and Müller cells.

"We were focusing on what would happen with the photoreceptor cells, the cells that we knew were dying," Beltran said. "But what our results are telling us is that, sure, they are dying, but there is something else happening with the cells that they talk to."

Pharmaceutical companies have already developed TNF-inhibitors to treat diseases like rheumatoid arthritis. Genini, Beltran and Aguirre say their results suggest that these drugs or similar ones might have a role to play in the retinal diseases they investigated and perhaps in others that their team is currently studying.

"On its own," Beltran said, "a TNF-inhibitor might not be a cure, but it could be used complementary to gene therapy, either by slowing the course of degeneration before the corrective gene therapy is delivered or in combination with the corrective gene therapy."



INFORMATION:



The research was supported by the Foundation Fighting Blindness, the National Institutes of Health, the Van Sloun Fund for Canine Genetic Research, Hope for Vision and the Macula Vision Research Foundation.



ELSE PRESS RELEASES FROM THIS DATE:

National Park Service and outside experts collaborate to conserve migratory wildlife

2014-01-17
National Park Service and outside experts collaborate to conserve migratory wildlife A new paper details a collaboration between the National Park Service (NPS) and outside experts, including Wildlife Conservation Society (WCS) scientists, in developing recommendations ...

Prion discovery could help keep deadly brain diseases in check

2014-01-17
Prion discovery could help keep deadly brain diseases in check New research from David Westaway, PhD, of the University of Alberta and Jiri Safar, PhD, Case Western Reserve University School of Medicine has uncovered a quality control mechanism in brain cells ...

Loyola researchers identify risk factor for life-threatening disease in preemies

2014-01-17
Loyola researchers identify risk factor for life-threatening disease in preemies Many premature infants suffer a life-threatening bowel infection called necrotizing enterocolitis (NEC). Researchers at Loyola University Health System have identified a marker ...

Parietal gray matter volume changes may be associated with early PD memory deficits

2014-01-17
Parietal gray matter volume changes may be associated with early PD memory deficits New findings published in the Journal of Parkinson's Disease Amsterdam, NL, 16 January 2014 – Research by a team of investigators in Finland suggests that the free recall memory deficits common ...

Penn Museum team finds evidence for 3,000+-year-old 'Nordic grog' tradition

2014-01-17
Penn Museum team finds evidence for 3,000+-year-old 'Nordic grog' tradition Discovery highlights innovative and complex fermented beverages of northernmost Europe in the Bronze and Iron Ages From northwest Denmark, circa 1500-1300 BC, to the Swedish island of Gotland ...

Higher vitamin D levels associated with better cognition and mood in PD patients

2014-01-17
Higher vitamin D levels associated with better cognition and mood in PD patients Findings published in the Journal of Parkinson's Disease Amsterdam, NL, 16 January 2014 – A new study exploring vitamin D levels in patients with Parkinson's disease (PD) opens up the possibility ...

Sarcophagus leads Penn Museum team in Egypt to the tomb of a previously unknown pharaoh

2014-01-17
Sarcophagus leads Penn Museum team in Egypt to the tomb of a previously unknown pharaoh Discovery provides evidence of a forgotten Egyptian dynasty from 3,600 years ago Archaeologists working at the southern Egyptian site of Abydos have discovered the tomb of a previously ...

Big-headed fossil flies track major ecological revolution

2014-01-17
Big-headed fossil flies track major ecological revolution Simon Fraser University's Bruce Archibald and Rolf Mathewes are part of a team of biologists, including Christian Kehlmaier from Germany's Senkenberg Natural History Collections, that has discovered three new, ...

Statin use reduces delirium in critically ill patients

2014-01-17
Statin use reduces delirium in critically ill patients Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission, according to a new study of 470 intensive care patients in the UK. "This is the first ...

Vitamin D supplements reduce pain in fibromyalgia sufferers

2014-01-17
Vitamin D supplements reduce pain in fibromyalgia sufferers Researchers say Vitamin D may be cost-effective treatment or adjunct for patients with fibromyalgia syndrome and low vitamin D levels, reports PAIN® Philadelphia, January 17, 2014 – Patients with fibromyalgia ...

LAST 30 PRESS RELEASES:

Mayo Clinic study reveals hidden causes of heart attacks in younger adults, especially women

Target: BP initiative helps more than 10M adults with hypertension

New initiative launched to improve care for people with certain types of heart failure

You’ve never seen corn like this before

Mediterranean diet could reduce gum disease

Mount Sinai launches cardiac catheterization artificial intelligence research lab

Why AI is never going to run the world

Stress in the strands: Hair offers clues to children’s mental health

UCLA distinguished professor, CVD researcher to receive 2025 Basic Research Prize

UT San Antonio School of Public Health: The People’s School

‘Preventable deaths will continue’ without action to make NHS more accessible for autistic people, say experts

Scientists shoot lasers into brain cells to uncover how illusions work

Your ecosystem engineer was a dinosaur

New digital cognitive test for diagnosing Alzheimer's disease

Parents of children with health conditions less confident about a positive school year

New guideline standardizes consent for research participants in Canada

Research as reconciliation: Oil sands and health

AI risks overwriting history and the skills of historians have never been more important, leading academic outlines in new paper

The Lancet Diabetes & Endocrinology: Higher doses of semaglutide can safely enhance weight loss and improve health for adults living with obesity, two new clinical trials confirm

Trauma focused therapy shows promise for children struggling with PTSD

School meals could drive economic growth and food system transformation

Home training for cerebellar ataxias

Dry eyes affect over half the general population, yet only a fifth receive diagnosis and treatment

Researchers sound warning about women with type 2 diabetes taking oral HRT

Overweight and obesity don’t always increase the risk of an early death, Danish study finds

Cannabis use associated with a quadrupling of risk of developing type 2 diabetes, finds study of over 4 million adults

Gestational diabetes linked to cognitive decline in mothers and increased risk of developmental delays, ADHD and autism among children

Could we use eye drops instead of reading glasses as we age?

Patients who had cataracts removed or their eyesight corrected with a new type of lens have good vision over all distances without spectacles

AI can spot which patients need treatment to prevent vision loss in young adults

[Press-News.org] Same cell death pathway involved in three forms of blindness, Penn team finds